Kidney injury molecule-1 and neutrophil gelatinase associated lipocalin in normoalbuminuric diabetic children

Journal of Pediatric Endocrinology and Metabolism

Volumn 29, Issue 2, 2016, Pages 145-151

  Ucakturk, Ahmet ^a   Avci, Bahattin ^b   Genc, Gurkan ^b   Ozkaya, Ozan ^b   Aydin, Murat ^b  

^a Pediatric Immunology and Allergy Department   (Turkey)

^b ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

KIM 1; NGAL; type 1 diabetes (T1D)

Indexed keywords

ALBUMIN; CREATININE; HEMOGLOBIN A1C; KIDNEY INJURY MOLECULE 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; ALBUMINOID; HAVCR1 PROTEIN, HUMAN; LCN2 PROTEIN, HUMAN; LIPOCALIN; MEMBRANE PROTEIN; ONCOPROTEIN; VIRUS RECEPTOR;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE DURATION; ELISA KIT; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; URINE LEVEL; CASE CONTROL STUDY; METABOLISM;

ACUTE-PHASE PROTEINS; ADOLESCENT; ALBUMINS; CASE-CONTROL STUDIES; CHILD; FEMALE; HEPATITIS A VIRUS CELLULAR RECEPTOR 1; HUMANS; LIPOCALIN-2; LIPOCALINS; MALE; MEMBRANE GLYCOPROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, VIRUS;

EID: 84958183650     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/jpem-2015-0138     Document Type: Article

References (44)

1. Kiess W, Gorski T, Penke M, Klamt S, Kapellen TM. Diabetes mellitus in children and adolescents - a global epidemic which has become neglected. J Pediatr Endocrinol Metab 2015; 28: 247-50
2. Marcovecchio ML, Tossavainen PH, Dunger DB. Prevention and treatment of microvascular disease in childhood type 1 diabetes. Br Med Bull 2010; 94: 145-64
3. Serban V, Brink S, Timar B, Sima A, Vlad M., et al. An increasing incidence of type 1 diabetes mellitus in Romanian children aged 0 to 17 years. J Pediatr Endocrinol Metab 2015; 28: 293-8
4. Molitch ME, Steffes M, Sun W, Rutledge B, Cleary P., et al. Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study. Diabetes Care 2010; 33: 1536-43
5. Najafian B, Mauer M. Progression of diabetic nephropathy in type 1 diabetic patients. Diabetes Res Clin Pract 2009; 83: 1-8
6. Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?. Kidney Int 1999; 56: 1627-37
7. Parving H-H, Mauer M, Ritz E. Diabetic nephropathy. In: Brenner BM, editor. Brenner & Rectors THE KIDNEY, 8th edn. Boston: WB Saunders, 2008: 1265-98
8. Magri CJ, Fava S. The role of tubular injury in diabetic nephropathy. Epub 2009 Jan 30. Review. Eur J Intern Med 2009; 20: 551-5
9. Van Timmeren MM, Van den Heuvel MC, Bailly V, Bakker SJ, Van Goor H., et al. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol 2007; 212: 209-17
10. Cowland JB, Sorensen OE, Sehested M, Borregaard N. Neutrophil gelatinase-Associated lipocalin is up-regulated in human epithelial cells by IL-1b, but not by TNF-A. J Immunol 2003; 171: 6630-9
11. Soni SS, Cruz D, Bobek I, Chionh CY, Nalesso F., et al. NGAL: a biomarker of acute kidney injury and other systemic conditions. Review. Int Urol Nephrol 2010; 42: 141-50
12. Bundak R, Furman A, Gunoz H, Darendeliler F, Bas F., et al. Body mass index references for Turkish children. Acta Paediatr 2006; 95: 194-8
13. Urbina E, Alpert B, Flynn J, Hayman L, Harshfield GA., et al. Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the council on cardiovascular disease in the young and the council for high blood pressure research. Hypertension 2008; 52: 433-51
14. Wei W, Tölle M, Zidek W, Van der Giet M. Validation of the mobil-O-Graph: 24 h-blood pressure measurement device. Blood Press Monit 2010; 15: 225-8
15. Stergiou GS, Alamara C, Drakatos A, Stefanidis CJ, Vazeou A. Prediction of albuminuria by different blood pressure measurement methods in type 1 diabetes: a pilot study. Hypertens Res 2009; 32: 680-4
16. Wühl E, Witte K, Soergel M, Mehls O, Schaefer F., et al. Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 2002; 20: 1995-2007
17. Craig ME, Hattersley A, Donaghue KC. Definition, epidemiology and classification of diabetes in children and adolescents. Pediatr Diabetes 2009; 10: 3-12
18. Fioretto P, Mauer M, Brocco E, Velussi M, Frigato F., et al. Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia 1996; 39: 1569-76
19. Nauta FL, Boertien WE, Bakker SJ, Van Goor H, Van Oeveren W., et al. Glomerular and tubular damage markers are elevated in patients with diabetes. Diabetes Care 2011; 34; 975-81
20. Waanders F, Van Timmeren MM, Stegeman CA, Bakker SJ, Van Goor H. Kidney injurymolecule-1 in renal disease. Review. J Pathol 2010; 220: 7-16
21. Bodin S, Chollet C, Goncalves-Mendes N, Gardes J, Pean F., et al. Kallikrein protects against microalbuminuria in experimental type I diabetes. Kidney Int 2009; 76: 395-403
22. Nielsen SE, Schjoedt KJ, Astrup AS, Tarnow L, Lajer M., et al. Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril. Diabet Med 2010; 27: 1144-50
23. Fu WJ, Xiong SL, Fang YG, Wen S, Chen ML., et al. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study. Endocrine 2012; 41: 82-8
24. Bolignano D, Lacquaniti A, Coppolino G, Donato V, Fazio MR., et al. Neutrophil gelatinase-Associated lipocalin as an early biomarker of nephropathy in diabetic patients. Kidney Blood Press Res 2009; 32: 91-8
25. Nielsen SE, Andersen S, Zdunek D, Hess G, Parving HH., et al. Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy. Kidney Int 2011; 79: 1113-18
26. Zachwieja J, Soltysiak J, Fichna P, Lipkowska K, Stankiewicz W., et al. Normal-range albuminuria does not exclude nephropathy in diab etic children. Pediatr Nephrol 2010; 25; 1445-51
27. Demir K, Abaci A, Küme T, Altincik A, Catli G., et al. Evaluation of neutrophil gelatinase-Associated lipocalin in normoalbuminuric normotensive type 1 diabetic adolescents. J Pediatr Endocrinol Metab 2012; 25: 517-23
28. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 2002; 62: 237-44
29. Devarajan P. Review: neutrophil gelatinase-Associated lipocalin: a troponin-like biomarker for human acute kidney injury. Nephrology 2010; 15; 419-28
30. Clerico A, Galli C, Fortunato A, Ronco C. Neutrophil gelatinaseassociated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences. Clin Chem Lab Med 2012; 50: 1505-17
31. Garg V, Kumar M, Mahapatra HS, Chitkara A, Gadpayle AK., et al. Novel urinary biomarkers in pre-diabetic nephropathy. Clin Exp Nephrol 2015. [Epub ahead of print], PMID: 25634253
32. Wu C, Wang Q, Lv C, Qin N, Lei S., et al. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin. Diabetes Res Clin Pract 2014; 106: 343-50
33. Simonazzi G, Capelli I, Curti A, Comai G, Rizzo N., et al. Serum and urinary neutrophil gelatinase-Associated lipocalin monitoring in normal pregnancy versus pregnancies complicated by pre-eclampsia. In Vivo 2015; 29: 117-21
34. Sachan R, Patel M, Gaurav A, Gangwar R, Sachan P. Correlation of serum neutrophil gelatinase associated lipocalin with disease severity in hypertensive disorders of pregnancy. Adv Biomed Res 2014; 3: 223
35. Imamaki H, Ishii A, Yokoi H, Kasahara M, Kuwabara T., et al. Low serum neutrophil gelatinase-Associated lipocalin level as a marker of malnutrition in maintenance hemodialysis patients. PLoS One 2015; 10: e0132539
36. Cangemi G, Storti S, Cantinotti M, Fortunato A, Emdin M., et al. Reference values for urinary neutrophil gelatinase-Associated lipocalin (NGAL) in pediatric age measured with a fully automated chemiluminescent platform. Clin Chem Lab Med 2013; 51: 1101-5
37. Myers GL, Miller WG, Coresh J, Fleming J, Greenberg N., et al. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 2006; 52: 5-18
38. International Federation of Clinical Chemistry and Laboratory Medicine, Working Group on Standardization of Glomerular Filtration Rate Assessment (WG-GFRA), Panteghini M, Myers GL, Miller WG., et al. The importance of metrological traceability on the validity of creatinine measurement as an index of renal function. Clin Chem Lab Med 2006; 44: 1287-92
39. Andrassy KM. Comments on KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int 2013; 84: 622-3
40. Bacchetta J, Cochat P, Rognant N, Ranchin B, Hadj-Aissa A., et al. Which creatinine and cystatin C equations can be reliably used in children?. Clin J Am Soc Nephrol 2011; 6: 552-60
41. Hvidt KN, Olsen MH, Holm JC, Ibsen H. Obese children and adolescents have elevated nighttime blood pressure independent of insulin resistance and arterial stiffness. Am J Hypertens 2014; 27: 1408-15
42. Menon S, Kirkendall ES, Nguyen H, Goldstein SL. Acute kidney injury associated with high nephrotoxic medication exposure leads to chronic kidney disease after 6 months. J Pediatr 2014; 165: 522-7.e2
43. Hailpern SM, Egan BM, Lewis KD, Wagner C, Shattat GF., et al. Blood pressure, heart rate, and cns stimulant medication use in children with and without ADHD: analysis of NHANES data. Front Pediatr 2014; 2: 100
44. Bonito P, Sanguigno E, Forziato C, Di Fraia T, Moio N., et al. Glomerular filtration rate and cardiometabolic risk in an outpatient pediatric population with high prevalence of obesity. Obesity (Silver Spring) 2014; 22: 585-9